作者: gout109 時(shí)間: 2025-3-21 20:16 作者: Emmenagogue 時(shí)間: 2025-3-22 02:44 作者: Inelasticity 時(shí)間: 2025-3-22 07:25 作者: 不吉祥的女人 時(shí)間: 2025-3-22 10:23
Current and Emerging Role of Chemotherapy in Oral Cancer,It can be offered as a single modality treatment for palliation, in combination with concomitant radiation therapy (chemoradiation) as either adjuvant therapy following surgical resection or primary definitive treatment for locally advanced disease, or as induction therapy prior to definitive treatm作者: Euphonious 時(shí)間: 2025-3-22 16:25 作者: Euphonious 時(shí)間: 2025-3-22 21:00
Management of the Neck in Oral Cavity Cancer,5-year relative survival rate between 1975–1978 and 2002–2008 of 53 % vs 65 % for all races, 54 % vs 67 % for whites, and 36 % vs 45 % for blacks. All of these were statistically significant (. < .05), although survival is still worse in blacks than whites [1]. This data is not true on global scale,作者: inconceivable 時(shí)間: 2025-3-22 21:40
Sentinel Node Biopsy in Oral Cancer,ence of occult metastasis, even in patients with no clinical or radiological evidence of lymph nodal metastasis (N0). This ranges from 10 to 50?% depending on the primary tumor characteristics [2–4]. Despite this, we currently have no accepted noninvasive diagnostic modality for identification of oc作者: dendrites 時(shí)間: 2025-3-23 02:51
Pearls and Pitfalls in Oral Cancer Management,e art of medical practice aims to recognize high-risk scenarios and take measures to minimize pitfalls. The clinical outcome should be periodically audited to recognize patterns of complications and to implement remedial actions to correct these errors. The effectiveness of the remedial actions also作者: 細(xì)胞 時(shí)間: 2025-3-23 05:49 作者: 歸功于 時(shí)間: 2025-3-23 13:00
Biological Basis of Treatment Failure,te. However intensification of locoregional therapy especially with the use of postoperative adjuvant chemoradiotherapy, a higher proportion of disease failures, is seen at the distant site. Recurrent disease is often resistant to treatment and often an indicator of incurability, especially those wi作者: 能得到 時(shí)間: 2025-3-23 16:01
Vavilov-Cherenkov and Synchrotron Radiationl identification and evaluation of an oral lesion is undertaken by a primary healthcare giver—dentists, primary care physicians, oral surgeons, and general practitioners—before referring to a tertiary care center. Accurate diagnosis and staging at the initial visit is vital to appropriate decision-m作者: Pelvic-Floor 時(shí)間: 2025-3-23 20:33 作者: 細(xì)頸瓶 時(shí)間: 2025-3-23 22:38 作者: 教唆 時(shí)間: 2025-3-24 06:20 作者: 癡呆 時(shí)間: 2025-3-24 07:35 作者: 線 時(shí)間: 2025-3-24 11:02 作者: enfeeble 時(shí)間: 2025-3-24 18:00
Vavilov-Cherenkov and Synchrotron Radiation5-year relative survival rate between 1975–1978 and 2002–2008 of 53 % vs 65 % for all races, 54 % vs 67 % for whites, and 36 % vs 45 % for blacks. All of these were statistically significant (. < .05), although survival is still worse in blacks than whites [1]. This data is not true on global scale,作者: 領(lǐng)導(dǎo)權(quán) 時(shí)間: 2025-3-24 19:58 作者: Emg827 時(shí)間: 2025-3-24 23:55
Cherenkov Radiation in a Dispersive Medium,e art of medical practice aims to recognize high-risk scenarios and take measures to minimize pitfalls. The clinical outcome should be periodically audited to recognize patterns of complications and to implement remedial actions to correct these errors. The effectiveness of the remedial actions also作者: GENRE 時(shí)間: 2025-3-25 06:40 作者: cataract 時(shí)間: 2025-3-25 11:26 作者: spinal-stenosis 時(shí)間: 2025-3-25 14:34
Surgical Management of Oral Squamous Cell Carcinoma,f spread of tumors of different subsites, and instrumentation, several technical modifications have been adopted in the recent past to improve oncological, functional, and aesthetic outcome of ablative surgery for oral cancer.作者: labile 時(shí)間: 2025-3-25 16:38 作者: 愉快么 時(shí)間: 2025-3-25 23:42 作者: faddish 時(shí)間: 2025-3-26 00:45
http://image.papertrans.cn/c/image/236633.jpg作者: burnish 時(shí)間: 2025-3-26 04:33
https://doi.org/10.1007/978-3-319-14917-2Ablative Surgery; Chemotherapy; Imaging; Lymph Node Biopsy; Oral Cavity Cancer; Radiation; surgical oncolo作者: 天賦 時(shí)間: 2025-3-26 12:26 作者: 棲息地 時(shí)間: 2025-3-26 14:32 作者: 減少 時(shí)間: 2025-3-26 17:04 作者: 少量 時(shí)間: 2025-3-26 22:27
Correction to: Sentinel Node Biopsy in Oral Cancer,作者: 羞辱 時(shí)間: 2025-3-27 03:35 作者: 無(wú)可非議 時(shí)間: 2025-3-27 09:20
Current and Emerging Role of Chemotherapy in Oral Cancer,therapy, novel targeted therapy has demonstrated its efficacy in palliation [4]. Although most of the studies of chemotherapy in HNSCC were not site specific, many of the findings may be applicable to oral cancers.作者: 招致 時(shí)間: 2025-3-27 09:43 作者: 歹徒 時(shí)間: 2025-3-27 17:18
Vavilov-Cherenkov and Synchrotron Radiationriate interventions and identify comorbidities that may influence treatment choices. Attempt also should be made to elicit social support network the patient has to facilitate treatment and surveillance.作者: 致詞 時(shí)間: 2025-3-27 19:51
Vavilov-Cherenkov and Synchrotron Radiationtherapy, novel targeted therapy has demonstrated its efficacy in palliation [4]. Although most of the studies of chemotherapy in HNSCC were not site specific, many of the findings may be applicable to oral cancers.作者: Allodynia 時(shí)間: 2025-3-28 00:40
Book 2017er from a multidisciplinary perspective and on the basis of a strong scientific foundation. This volume addresses a range of management issues in oral cancer, from imaging and staging through to the roles of radiation therapy and chemotherapy. Principles of ablative surgery are explained, and neck d作者: CBC471 時(shí)間: 2025-3-28 03:01 作者: 到婚嫁年齡 時(shí)間: 2025-3-28 07:32
Management of the Neck in Oral Cavity Cancer, of these were statistically significant (. < .05), although survival is still worse in blacks than whites [1]. This data is not true on global scale, and in many countries such as the Indian subcontinent, oral cavity cancer is more commonly seen due to habits such as the chewing of Betel Nut.作者: venous-leak 時(shí)間: 2025-3-28 14:15 作者: KEGEL 時(shí)間: 2025-3-28 15:09 作者: GIDDY 時(shí)間: 2025-3-28 20:43 作者: ALIBI 時(shí)間: 2025-3-29 02:24 作者: 寵愛(ài) 時(shí)間: 2025-3-29 06:15 作者: POWER 時(shí)間: 2025-3-29 10:35 作者: addition 時(shí)間: 2025-3-29 14:20
Radiotherapy in the Management of Carcinoma of the Oral Cavity,the presence of adverse pathologic features. Not all patients, however, are able or willing to undergo surgery; consequently, certain cases may be managed with (chemo- and/or) radiotherapy alone. This chapter will briefly review the use of radiation therapy in the treatment of oral cavity cancers.
